Pentixapharm Holding AG (FRA:PTP) Other Current Liabilities: €1.09 Mil (As of Mar. 2026)


FRA:PTP Pentixapharm Holding AG FRA:PTP
20 GF Score
Price €2.20
! 2 Warning Signs
View Full Analysis

What is Pentixapharm Holding AG Other Current Liabilities?

Pentixapharm Holding AG FRA:PTP -4.35% 20 Other Current Liabilities is €1.09 Mil as of Mar. 2026. GuruFocus rates FRA:PTP with a GF Score™ of 20/100. The stock has 2 warning signs investors should review.

Pentixapharm Holding AG's other current liabilities for the quarter that ended in Mar. 2026 was €1.09 Mil.

Pentixapharm Holding AG's quarterly other current liabilities declined from Sep. 2025 (€1.08 Mil) to Dec. 2025 (€0.95 Mil) but then increased from Dec. 2025 (€0.95 Mil) to Mar. 2026 (€1.09 Mil).

Pentixapharm Holding AG's annual other current liabilities declined from Dec. 2023 (€6.80 Mil) to Dec. 2024 (€5.02 Mil) and declined from Dec. 2024 (€5.02 Mil) to Dec. 2025 (€0.95 Mil).

Pentixapharm Holding AG Other Current Liabilities Related Terms

Pentixapharm Holding AG Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Pentixapharm Holding AG's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pentixapharm Holding AG Other Current Liabilities Chart

Pentixapharm Holding AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
0.10 1.63 6.80 5.02 0.95

Pentixapharm Holding AG Quarterly Data
Dec21 Dec22 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 4.99 4.84 1.08 0.95 1.09
FRA:PTP
20GF Score
Pentixapharm Holding AG FRA:PTP
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pentixapharm Holding AG Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €1.09 Mil mean?
Pentixapharm Holding AG (FRA:PTP) has a Other Current Liabilities of €1.09 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Pentixapharm Holding AG.
Is Pentixapharm Holding AG's Other Current Liabilities too high?
Pentixapharm Holding AG's current Other Current Liabilities is €1.09 Mil. Overall, Pentixapharm Holding AG has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Pentixapharm Holding AG's Other Current Liabilities compare to VRTX and REGN?
Pentixapharm Holding AG's Other Current Liabilities of €1.09 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Pentixapharm Holding AG. Pentixapharm Holding AG's current Other Current Liabilities is €1.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pentixapharm Holding AG stock overvalued right now?
Pentixapharm Holding AG (FRA:PTP) has a current Other Current Liabilities of €1.09 Mil. The current Other Current Liabilities is €1.09 Mil. Pentixapharm Holding AG's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Pentixapharm Holding AG (FRA:PTP), the current Other Current Liabilities is €1.09 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pentixapharm Holding AG Business Description

Other Exchanges PTP:GermanyPTPN:Austria
Address Robert-Rossle-Street 10, Berlin, DEU, 13125
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic. Its Pipeline products include: Pentixa Ther, PT-002, PentixaFor, PT-001, PentixaFor, PT-001, PT-00X, GT-001, GT-002, GT-005, GT-008, and GT-00X.
20GF Score

Get the complete analysis for FRA:PTP

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.20
Price